Snowden Capital Advisors LLC Grifols Sa Transaction History

Snowden Capital Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$10.37 - $12.73 $4,604 - $5,652	-444 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.21 - $15.27 $4,533 - $6,779	444 New	444 $4,000
Q1 2020 Jan 08, 2024	SELL	$16.28 - $25.63 $1.29 Million - $2.03 Million	-79,200 Closed	0 $0
Q4 2019 Jan 08, 2024	SELL	$19.57 - $23.52 $258,324 - $310,464	-13,200 Reduced 14.29%	79,200 $18.4 Million
Q3 2019 Jan 08, 2024	BUY	$19.85 - $22.76 $1.44 Million - $1.65 Million	72,400 Added 362.0%	92,400 $18.5 Million
Q2 2019 Jan 08, 2024	BUY	$17.59 - $21.1 $351,800 - $422,000	20,000 New	20,000 $22.2 Million

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $4.89B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Snowden Capital Advisors LLC with notifications on news.